FdaApplication
ANDA 210275
Identifiers
- fda_app_no: ANDA210275
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2022-01-26 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| POMALIDOMIDE | POMALIDOMIDE | 4MG | CAPSULE;ORAL |
| POMALIDOMIDE | POMALIDOMIDE | 3MG | CAPSULE;ORAL |
| POMALIDOMIDE | POMALIDOMIDE | 2MG | CAPSULE;ORAL |
| POMALIDOMIDE | POMALIDOMIDE | 1MG | CAPSULE;ORAL |
4 products